Deoxynucleotide (dNTP) Solution Mix is an equimolar solution of ultrapure dATP, dCTP, dGTP and dTTP…

The University of Virginia awarded a purchase order contract (A207_PO-0433570-V3) to New England Biolabs Inc on October 10, 2026, for the supply of deoxynucleotide (dNTP) Solution Mix. The contract is valued at $70 and specifies delivery of 70 units of dNTP Solution Mix at $1 per unit. The deoxynucleotide solution is an equimolar formulation containing ultrapure deoxyadenosine triphosphate (dATP), deoxycytidine triphosphate (dCTP), deoxyguanosine triphosphate (dGTP), and deoxythymidine triphosphate (dTTP) suspended in ultrapure water as a sodium salt at pH 7.5.

The product is available in two pack configurations: small packs containing four vials of 0.2 milliliters each, and large packs containing five vials of 0.8 milliliters each. The contract specifies delivery to the buyer, with the contracting organization being the University of Virginia, a state institution in Virginia. No specific period of performance, county designation, or place of performance other than the buyer's location is identified in the available contract documentation.